Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients
Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients
Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients
Submitted by
admin
on December 31, 2013 - 11:36am
Source:
Pharmabiz.com
News Tags:
FDA
Veloxis
Envarsus
kidney translants
Headline:
Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients
Do Not Allow Advertisers to Use My Personal information
